Stocks and Investing Stocks and Investing
Wed, April 29, 2020

Andrew Fein Reiterated (BPMC) at Strong Buy with Decreased Target to $66 on, Apr 29th, 2020


Published on 2024-10-27 04:26:58 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Reiterated "Blueprint Medicines Corporation" (BPMC) at Strong Buy with Decreased Target from $100 to $66 on, Apr 29th, 2020.

Andrew, nor any peers, have made any analyst calls on BPMC in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources